Thông tư 46/2016/TT-BYT

Circular No. 46/2016/TT-BYT dated December 30, 2016, list of diseases requiring long-term treatment

Nội dung toàn văn Circular 46/2016/TT-BYT list diseases requiring long term treatment


MINISTRY OF HEALTH
--------

SOCIALIST REPUBLIC OF VIETNAM
Independence - Freedom - Happiness
---------------

No. 46/2016/TT-BYT

Hanoi, December 30, 2016

 

CIRCULAR

LIST OF DISEASES REQUIRING LONG-TERM TREATMENT

Pursuant to the Law on Social insurance No. 58/2014/QH13 dated November 20, 2014 by the National Assembly of Socialist Republic of Vietnam;

Pursuant to the Government's Decree No. 63/2012/ND-CP dated August 31, 2012 defining the functions, tasks, powers and organizational structure of the Ministry of Health;

At the request of Director of Medical Examination & Treatment Administration,

The Minister of Health promulgates the list of diseases requiring long-term treatment.

Article 1. List of diseases requiring long-term treatment

1. The list of diseases requiring long-term treatment is promulgated together with this Circular.

2. The list of diseases requiring long-term treatment is the basis for provision of benefits for employee under the Law on Social insurance.

3. Codes and names of diseases on the list of diseases requiring long-term treatment:

a) The diseases on the list of diseases requiring long-term treatment are coded according to ICD-10. A 4-digit disease belongs to a 3-digit group.

Example: The code of fibrosis and cirrhosis of liver is K74, including:

- Hepatic fibrosis: K74.0

- Hepatic sclerosis: K74.1

- Hepatic fibrosis with hepatic sclerosis: K74.2

- Primary biliary cirrhosis: K74.3

- Secondary biliary cirrhosis: K74.4

- Biliary cirrhosis, unspecified: K74.5

- Other and unspecified cirrhosis of liver: K74.6

b) Some diseases that are not coded according to ICD-10 shall be named according to diagnosis.

Example: Infection caused by multi-drug resistant bacteria, autoimmune pancreatitis.

Article 2. Effect

This Circular comes into force from March 01, 2017.

Appendix I of Circular No. 14/2016/TT-BYT is annulled from the effective date of this Circular.

Article 3. Responsibility for implementation

1. Director of Medical Examination & Treatment Administration shall take charge and cooperate with relevant units in providing guidance, organizing and inspecting the implementation of this Circular by health facilities.

2. Directors of Departments of Health of provinces, heads of health departments of ministries shall provide guidance, organize and inspect the implementation of this Circular by health facilities under their management.

3. Heads of health facilities are responsible for organize diagnosis of diseases on the list enclosed with this Circular and take legal responsibility for such diagnosis.

Difficulties that arise during the implementation of this Circular should be reported to Medical Examination & Treatment Administration, which is affiliated to the Ministry of Health, for consideration.

 

 

PP MINISTER
DEPUTY MINISTER



Nguyen Viet Tien

 

LIST

OF DISEASES REQUIRING LONG-TERM TREATMENT
(Promulgated together with Circular No. 46/2016/TT-BYT)

No.

Disease

Code under ICD-10

I

Infectious and parasitic diseases

1.

Amebiasis (in intestines and liver)

A06

2.

Prolonged diarrhoea

A09

3.

Tuberculosis and sequelae

A15 - A19

4.

Diseases caused by atypical tubercle bacilli (found everywhere, including skin, glands, lung)

A15.3

5.

Withmore disease

A24.4

6.

Brucellosis

A23

7.

Severe tetanus and sequelae

A35

8.

Leprosy and sequelae

A30, B92

9.

Sequelae of tuberculosis of bones and joints

B90.2

10.

Chronic viral hepatitis B

B18.1

11.

Chronic viral hepatitis C

B18.2

12.

Chronic viral hepatitis D

B18.8

13.

Chronic hepatitis E

B18.8

14.

HIV/AIDS

B20 - B24, Z21

15.

Sequelae of bacterial, viral and parasitic meningitis and encephalitis

B94.1, B94.8, B94.9

16.

Candidal meningitis, cerebral cryptococcosis

B37.5, B45.1

17.

Coccidioidomycosis

B38 - B46

18.

Cryptococcosis

B45

19.

Penicillosis

B48.4

20.

Plasmodium falciparum malaria with cerebral complications

B50.0

21.

Severe or complicated Plasmodium falciparum malaria

B50.8

22.

Diphyllobothriasis and sparganosis

B70

23.

Trichinellosis

B75

24.

Clonorchiasis

B66.1

25.

Fascioliasis

B66.3

26.

Parasitic infections (Toxocara, Cysticerose, Stronglyloides, …)

B89

27.

Multi-drug resistant bacterial infection

 

28.

Streptococcal meningitis

G00.2

29.

Endocarditis

I33

30.

Chronic sinusitis

J32

31.

Alcoholic hepatitis

K70.5

32.

Tuberculous arthritis

M01.1

33.

Spinal tuberculosis

M49.0

34.

Recurrent urinary tract infections

N00

II

Neoplasm

35.

Neoplasm

C00 - C97;

D00 - D09

36.

Benign neoplasm of bone and articular cartilage

D16

37.

Benign neoplasm of adrenal gland

D35.0

38.

Neoplasms of uncertain behavior

D37 - D48

III

Diseases of the blood, blood-forming organs and other disorder involving the immune mechanism

39.

Thalassemia

D56

40.

Sickle-cell disorders

D57

41.

Other hereditary hemolytic anemias

D58

42.

Acquired hemolytic anemias

D59

43.

Paroxysmal nocturnal hemoglobinuria (Marchiafava syndrome)

D59.5

44.

- Acquired pure red cell aplasia

- Other aplastic anemias

D60

D61

45.

Hereditary factor VIII deficiency (Hemophilia A)

D66

46.

Hereditary factor IX deficiency (Hemophilia B)

D67

47.

Von Willebrand's disease

D68.0

48.

Hereditary factor XI deficiency

D68.1

49.

Hereditary deficiency of other clotting factors

D68.2

50.

Other specified coagulation defects

D68.8

51.

Qualitative platelet defects

D69.1

52.

 Idiopathic thrombocytopenic purpura

D69.3

53.

Primary thrombocythemia

D75.2

54.

Hemophagocytic syndrome, infection-associated

D76.2

55.

Sarcoidosis

D86

56.

Hypergammaglobulinemia, unspecified

D89.2

IV

Endocrine, nutritional and metabolic diseases

57.

Hypothyroidism

E03

58.

Thyrotoxicosis

E05

59.

Chronic thyroiditis

E06.2,3,4

60.

Hypoparathyroidism

E20.8

61.

Diabetes mellitus

E10 - E14

62.

Hyperinsulinemic hypoglycemia

E16.1

63.

Hyperparathyroidism and other disorders of parathyroid gland

E21

64.

Hyperfunction of pituitary gland

E22

65.

Diabetes insipidus

E23.2

66.

Cushing's syndrome

E24

67.

Hyperaldosteronism

E26

68.

Bartter syndrome

E26.8

69.

Disorders of adrenal gland

E27

70.

Polyglandular dysfunction

E31

71.

Wilson's disease

E83.0

72.

Hypokalemia + Potassium deficiency

E87.6

73.

Postprocedural hypothyroidism

E89.0

74.

Diabetes mellitus in pregnancy, childbirth, and the puerperium

O24

V

Mental and behavioral disorders

75.

Dementia caused by Alzheimer’s disease

F00

76.

Dementia in other diseases classified elsewhere

F02

77.

Unspecified dementia

F03

78.

Amnestic disorder, not associated with alcohol and other psychoactive substances

F04

79.

Mental disorders due to known physiological condition

F06

80.

Personality and behavioral disorders due to known physiological condition

F07

81.

Alcohol related personality and behavioral disorders

F10

82.

Schizophrenia

F20

83.

Schizotypal disorder

F21

84.

Persistent delusional disorders

F22

85.

Schizoaffective disorders

F25

86.

Bipolar disorder

F31

87.

Major depressive disorder, single episode

F32

88.

Major depressive disorder, recurrent

F33

89.

Persistent mood [affective] disorders

F34

90.

Phobic anxiety disorders

F40

91.

Other anxiety disorders

F41

92.

Obsessive-compulsive disorder

F42

93.

Post-traumatic stress disorder (PTSD)

F43.1

94.

Adjustment disorders

F43.2

95.

Somatoform disorders

F45

96.

Specific personality disorders

F60

97.

Mixed personality disorder and other personality disorders

F61

98.

Long-term personality change not associated with any brain damage or brain disease

F62

99.

Other disorders of adult personality and behavior

F68

100.

Mental retardation

F70 - F79

101.

Developmental disorders

F80 - F89

102.

Disorders of personality and behavior that generally have onset within the childhood or adolescent years

F90 - F98

VI

Diseases of the nervous system

103.

Vascular dementia

F01

104.

Amyotrophic lateral sclerosis (Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere)

G13

105.

Parkinson's disease

G20

106.

Secondary parkinsonism

G21

107.

Dystonia

G24

108.

Alzheimer's disease

G30

109.

Multiple Sclerosis

G35

110.

Subacute necrotizing myelitis of central nervous system

G37.4

111.

Epilepsy

G40

112.

Myasthenia gravis

G70.0

113.

Encephalitis, myelitis and encephalomyelitis

G04

114.

Sequelae of inflammatory diseases of central nervous system

G09

115.

Spinal muscular atrophy and related syndromes (including G12.2 - Motor neuron disease)

G12

116.

Neuromyelitisoptica

G36.0

117.

Transverse myelitis

G37.3

118.

Trigeminal neuralgia

G50.0

119.

Clonic hemifacial spasm

G51.3

120.

Shingles

G53.0

121.

Nerve root and plexus disorders

G54

122.

Guillain-Barre syndrome

G61.0

123.

Inflammatory polyneuropathy

G61

124.

Primary disorders of muscles

G71

125.

Other myopathies

G72

126.

Cerebral palsy

G80

127.

Paraplegia (paraparesis) and quadriplegia (quadriparesis)

G82

128.

Other diseases of spinal cord

G95

129.

Nontraumatic intracerebral hemorrhage

I61

130.

Cerebral infarction

I63

131.

Stroke due to either cerebral infarction or intracerebral hemorrhage

I64

132.

Sequelae of cerebrovascular disease

I69

133.

Congenital hydrocephalus

Q03

134.

Neuroblastomas

 

135.

Down syndrome

Q90

136.

Edward syndrome and Pateau syndrome

Q91

VII

Diseases of the eye and adnexa

137.

Dry eye syndrome

H04.1.2

138.

Keratitis

H16

139.

Lens-induced iridocyclitis

H20.2

140.

Hyphema

H21

141.

Harada syndrome

H30.8.1

142.

Chorioretinal inflammation

H30.9.1, H30.9.2

143.

Traction detachment of retina

H33.4.1

144.

Retinal vascular occlusions

H34.8

145.

Diabetic retinal disorders

H35

146.

Retinal inflammation caused by CMV

H35

147.

Retinal vasculitis

H35.0.6

148.

Retinopathy of prematurity

H35.1

149.

Central serous chorioretinopathy

H35.7.1

150.

Pathophysiology due to atherosclerosis

H36.6

151.

Glaucoma

H40

152.

Parasitic endophthalmitis

H44.1.2

153.

Nutritional optic neuropathy

H46.2

154.

Toxic optic neuropathy

H46.3

155.

Bệnh lí bề mặt nhãn cầu do hội chứng Stve Jonhson, hội chứng Lyell

 

156.

Corneal transplant status

Z94.7

VIII

Diseases of the ear and mastoid process

157.

Neoplasm of VII nerve

D43.3

158.

Neoplasm of VIII nerve

D43.3

159.

Sarcoidosis of ear

D86

160.

Papillomavirus in the larynx

B97.7

161.

Chronic otitis media

H66.3

162.

Complicated mastoiditis

H70.91

163.

Cholesteatoma of middle ear

H71

164.

Ménière's disease

H81.0

165.

Occupational hearing loss

H83.3

166.

Progressive hearing loss

H90.5

167.

Conductive hearing loss

H90.0

168.

Hearing loss caused by temporal bone injury

H91.8

169.

Chronic pharyngitis

K21

170.

Chronic sinusitis

J32

171.

Encephalocele

Q01

172.

Postintubation tracheal stenosis

Q32.4

173.

Turner's syndrome

Q96.9

174.

Injury to the trachea or larynx

S27.5, S11.96

IX

Diseases of the circulatory system

175.

Acute coronary syndrome

I20, I21, I22, I23

176.

Chronic ischemic heart disease

I25

177.

Pulmonary embolism

I26

178.

Other pulmonary heart diseases

I27

179.

Acute pericarditis

I30

180.

Chronic constrictive pericarditis

I31.1

181.

Myocarditis

I40

182.

Endocarditis

I33; I38

183.

Third-degree and fourth degree heart failure due to various reasons

I50

184.

Aortic aneurysm and dissection

I71

185.

Arterial embolism and thrombosis

I74

186.

Phlebitis and thrombophlebitis

I80

187.

Intraoperative and postprocedural complications

I97

188.

Complicated hypertension

I10

189.

Cardiomyopathy: Dilated cardiomyopathy; Congestive cardiomyopathy; Hypertrophic cardiomyopathy; Other cardiomyopathy

I42

190.

Other complicated hypertension (brain disease due to hypertension, transient stroke) with organ injury

I10

191.

Complicated congenital heart diseases;
Primary pulmonary arterial hypertension (other pulmonary heart diseases)

 

Q20-Q22

192.

Complicated valve diseases (arrhythmia, vascular occlusion, infection, others)

I08 - > I34, I35

193.

Atrial fibrillation and flutter

I48

194.

Complicated arrhythmia (…)

I49

195.

Pulmonary arteriovenous fistula

Q25.7, Q26

196.

Congenital malformations of pulmonary artery

Q25.7

X

Diseases of the respiratory system

197.

Chronic laryngitis

J37.0

198.

Polyp of vocal cord and larynx

J38.1

199.

Chronic obstructive pulmonary disease

J44

200.

Bronchial asthma

J45

201.

Bronchiectasis

J47

202.

Coalworker's pneumoconiosis

J60

203.

Asbestosis

J61

204.

Silicosis

J62

205.

Pneumoconiosis due to other inorganic dusts

J63

206.

Unspecified pneumoconiosis

J64

207.

Other interstitial pulmonary diseases

J84

208.

Abscess of lung and mediastinum

J85

209.

Pyothorax

J86

210.

Chronic respiratory failure (chest deformity)

J96, J96.1

211.

Chylous effusion

J94.0

212.

Cystic Fibrosis

E84

213.

Idiopathic pulmonary arterial hypertension

 

XI

Diseases of the digestive system

214.

Chronic hepatitis

K73

215.

Fibrosis and cirrhosis of liver

K74

216.

Autoimmune hepatitis

K75.4

217.

Calculus of bileduct with cholangitis

K80.3

218.

Chronic pancreatitis

K86.0; K86.1

219.

Crohn's disease

K50

220.

Primary biliary cirrhosis

K74.3

221.

Gastrointestinal bleeding

K52

222.

Wilson

 

223.

Autoimmune pancreatitis

 

XII

Diseases of the skin and subcutaneous tissue

224.

Pemphigus

L10

225.

Pemphigoid

L12

226.

Duhring's disease

L13.0

227.

Bullous pemphigoid

L14

228.

Atopic dermatitis

L20; L30

229.

Exfoliative dermatitis

L26

230.

Psoriasis

L40

231.

Pityriasis rubra pilaris

L44.0

232.

Erythema nodosum

L52

233.

Pyoderma gangrenosum

L88

234.

Chronic ulcer of skin

L98.4

235.

Parapsoriasis:

- Pityriasis lichenoides et varioliformis acuta

- Pityriasis lichenoides chronica

- Small plaque parapsoriasis

- Large plaque parapsoriasis

- Retiform parapsoriasis

- Other parapsoriasis

L41

L41.0

L41.1

L41.3

L41.4

L41.5

L41.8

236.

Chronic urticaria

L50

XIII

Diseases of the musculoskeletal system and connective tissue

237.

Systemic lupus erythematosus

M32

238.

Reactive arthropathies

M02.8, M02.9

239.

Rheumatoid arthritis

M05

240.

Psoriatic arthritis and arthritis in intestine pathology

M07.3

241.

Gout

M10

242.

Crystal arthropathies

M11

243.

Osteoarthritis of hip

M16

244.

Osteoarthritis of knee

M17

245.

Polyarteritis nodosa and related conditions

M30

246.

Other necrotizing vasculopathies

M31

247.

Dermatopolymyositis

M33

248.

Systemic sclerosis

M34

249.

Sjogren’s syndrome

M35.0

250.

Spondylolysis

M43

251.

Ankylosing spondylitis

M45

252.

Spondylosis

M47

253.

Cervical disc disorders

M50

254.

Adhesive capsulitis of shoulder

M75.0

255.

Osteoporosis with current pathological fracture

M80

256.

Nonunion

M84.1

257.

Pathological fracture

M84.4

258.

Fibrous dysplasia

M85.0

259.

Osteomyelitis

M86

260.

Idiopathic aseptic necrosis of bone

M87.0

261.

Algoneurodystrophy

M89.0

262.

Fracture of bone in neoplastic disease

M90.7

263.

Acquired deformities of musculoskeletal system and connective tissue

M95

264.

Pyogenic arthritis

M00

265.

Postinfective and reactive arthropathies in diseases classified elsewhere

M03

266.

Rheumatoid arthritis RF (-)

M06

267.

Adult-onset Still's disease

M06.1

268.

Juvenile arthritis

M08

269.

Juvenile arthritis in diseases in diseases classified elsewhere

M09

270.

Other arthritis

M13

271.

Polyosteoarthritis

M15

272.

Osteoarthritis of first carpometacarpal joint

M18

273.

Other osteoarthritis

M19

274.

Other specific joint derangements

M24

275.

Other systemic involvement of connective tissue

M35

276.

Systemic disorders of connective tissue in diseases classified elsewhere

M36

277.

Spondylopathies in diseases classified elsewhere

M49

278.

Other diseases of intervertebral disc

M51

279.

Other and unspecified dorsopathies, not elsewhere classified

M53

280.

Dorsalgia

M54

281.

Myositis

M60

282.

Calcification and ossification of muscle

M61

283.

Synovitis and tenosynovitis

M65

284.

Shoulder lesions

M75

285.

Panniculitis, unspecified

M79.3

286.

Fibromyalgia

M79.7

287.

Osteoporosis without current pathological fracture

M81

288.

Osteoporosis in other diseases

M82

289.

Adult osteomalacia

M83

290.

Paget's disease of bone

M88

XIV

Diseases of the genitourinary system

291.

Lupus nephritis

N01

292.

Recurrent and persistent hematuria

N02

293.

Chronic nephritic syndrome

N03

294.

Nephrotic syndrome

N04

295.

Primary and secondary glomerular disorders

N08

296.

Chronic tubulo-interstitial nephritis

N11

297.

Chronic kidney failure

N18

298.

Chronic cystitis

N30

299.

Incontinence

N39.3; N39.4

300.

Rò bàng quang - sinh dục nữ

N82

301.

Dị tật lỗ tiểu thấp

Q54

XV

Pregnancy, childbirth and the puerperium

302.

Hydatidiform mole

O01

303.

Complications following ectopic and molar pregnancy

O08 (O08.0-O08.9)

304.

Mild pre-eclampsia

O14.0

305.

Severe pre-eclampsia

O14.1

306.

Amniocentesis
(O42.2 is the code of premature rupture of membranes, which is also applicable)

O42.2

307.

Morbidly adherent placenta

O43.2

308.

Central placenta previa
(O44 is the code of placenta previa, which is also applicable since there is no separate code for central placenta previa) 

O44

XVI

Injury, poisoning and certain other consequences of external causes

309.

Injury of spinal cord with sequelae or complications

S34

310.

Injury of spine with sequelae or complications

S12, S14, S22.0, S32.0

311.

Traumatic brain injury with sequelae or complications

S06

312.

Intracranial injury with sequelae or complications

S06

313.

Injury of brachial plexus

S14.3

314.

Sprain of cruciate ligament of knee

S83.5

315.

Sequelae of surgery and accidents from treatment

 

316.

Sequelae of war-inflicted injuries

 

317.

Burn and corrosion of respiratory tract

T27

318.

Burn of multiple areas of the body

T29

319.

Burns involving 30-39% of body surface

T31.3

320.

Burns involving 40-49% of body surface

T31.4

321.

Burns involving 50-59% of body surface

T31.5

322.

Burns involving 60-69% of body surface

T31.6

323.

Burns involving 70-79% of body surface

T31.7

324.

Burns involving 80-89% of body surface

T31.8

325.

Burns involving 90% or more of body surface

T31.9

326.

Burn sequelae

T95

XVII

Factors influencing health status and contact with health services

327.

Corneal transplant

T86.84

328.

Artificial openings of digestive tract

Z43.4

329.

Artificial openings of unirary tract

Z43.6

330.

Hip replacement

Z69.64

331.

Knee replacement

Z69.65

332.

Organ transplant and post-transplant care

Z94

 

 


------------------------------------------------------------------------------------------------------
This translation is made by LawSoft and for reference purposes only. Its copyright is owned by LawSoft and protected under Clause 2, Article 14 of the Law on Intellectual Property.Your comments are always welcomed

Đã xem:

Đánh giá:  
 

Thuộc tính Văn bản pháp luật 46/2016/TT-BYT

Loại văn bảnThông tư
Số hiệu46/2016/TT-BYT
Cơ quan ban hành
Người ký
Ngày ban hành30/12/2016
Ngày hiệu lực01/03/2017
Ngày công báo...
Số công báo
Lĩnh vựcThể thao - Y tế
Tình trạng hiệu lựcCòn hiệu lực
Cập nhật7 năm trước
Yêu cầu cập nhật văn bản này

Download Văn bản pháp luật 46/2016/TT-BYT

Lược đồ Circular 46/2016/TT-BYT list diseases requiring long term treatment


Văn bản bị đính chính

    Văn bản được hướng dẫn

      Văn bản đính chính

        Văn bản bị thay thế

          Văn bản hiện thời

          Circular 46/2016/TT-BYT list diseases requiring long term treatment
          Loại văn bảnThông tư
          Số hiệu46/2016/TT-BYT
          Cơ quan ban hànhBộ Y tế
          Người kýNguyễn Viết Tiến
          Ngày ban hành30/12/2016
          Ngày hiệu lực01/03/2017
          Ngày công báo...
          Số công báo
          Lĩnh vựcThể thao - Y tế
          Tình trạng hiệu lựcCòn hiệu lực
          Cập nhật7 năm trước

          Văn bản thay thế

            Văn bản được dẫn chiếu

              Văn bản hướng dẫn

                Văn bản được hợp nhất

                  Văn bản được căn cứ

                  Văn bản hợp nhất

                    Văn bản gốc Circular 46/2016/TT-BYT list diseases requiring long term treatment

                    Lịch sử hiệu lực Circular 46/2016/TT-BYT list diseases requiring long term treatment

                    • 30/12/2016

                      Văn bản được ban hành

                      Trạng thái: Chưa có hiệu lực

                    • 01/03/2017

                      Văn bản có hiệu lực

                      Trạng thái: Có hiệu lực